DHR Health pioneers responsive neurostimulation therapy with NeuroPace Inc RNS System in Texas

DHR Health pioneers responsive neurostimulation therapy with NeuroPace Inc RNS System in Texas
NeuroPace Inc debuts RNS System

NeuroPace Inc announced that DHR Health has completed its first implant of the RNS System, introducing advanced responsive neurostimulation therapy to the Rio Grande Valley.

This development expands access to highly specialized epilepsy care for patients in the region, where options for advanced neurological treatment have previously been limited. By leveraging the RNS System, DHR Health aims to improve outcomes for those living with epilepsy who may not have responded to conventional therapies. The milestone marks a meaningful advancement in the availability of innovative medical technology in underserved areas.

NeuroPace previously reported a 62 percent median seizure reduction at six months for focal epilepsy patients in its largest FDA-reviewed study. The company has also noted that patients preferred the RNS System over VNS for its more targeted and immediate seizure control capabilities, according to comparative findings. These results have supported broader adoption of the device in clinical settings.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.